BioCentury | May 19, 2016
Distillery Therapeutics

Therapeutics: Catechol-O-methyl-transferase (COMT)

...Chem.; published online Apr. 13, 2016 doi:10.1021/acs.jmedchem.5b01970 CONTACT: Yan Luo, caprotec bioanalytics GmbH , Berlin, Germany e-mail: yan.luo@caprotec.com BC...
BioCentury | Oct 29, 2012
Company News

caprotec management update

caprotec bioanalytics GmbH , Berlin, Germany Business: Proteomics, Supply/Service Hired: Jonathan Turner as CEO and managing director, formerly SVP at XL Techgroup Inc.; he replaces Hubert Koester, who becomes acting CSO and chairman of the scientific...
BioCentury | May 16, 2011
Financial News

caprotec financial update

...to €5 million ($6.4 million). The company raised €4 million ($4.9 million) in May 2010. caprotec bioanalytics GmbH...
BioCentury | Oct 11, 2010
Company News

caprotec sales and marketing update

...caprotec bioanalytics GmbH , Berlin, Germany Business: Proteomics caprotec bioanalytics launched three new caproKits to investigate...
BioCentury | Oct 11, 2010
Company News

caprotec management update

caprotec bioanalytics GmbH , Berlin, Germany Business: Proteomics, Supply/Service Hired: Rainer Metternich as CBO, COO and a director, formerly VP and basic research site head at Merck & Co. Inc. WIR Staff...
BioCentury | May 24, 2010
Financial News

caprotec completes venture financing

caprotec bioanalytics GmbH , Berlin, Germany Business: Proteomics, Supply/Service Date completed: 5/13/10 Type: Venture financing Raised: €4 million ($4.9 million) Investors: Creathor Venture; IBB Beteiligungsgesellschaft; ERP Startfonds; private investors WIR Staff...
BioCentury | Feb 1, 2010
Company News

caprotec sales and marketing update

...histone deacetylases (HDACs) or GDP/GTP binding proteins, respectively. The kits are available for research use. caprotec bioanalytics GmbH...
BioCentury | Apr 13, 2009
Finance

Ebb & Flow

...company caprotec bioanalytics GmbH . The company markets its caproKits to discover, identify and characterize specific proteins. caprotec...
...Koster said the new round would go to building an internal drug pipeline based on caprotec's...
BioCentury | Jan 26, 2009
Company News

caprotec sales and marketing update

...characterize proteins that interact with S-adenosyl-L-homocysteine (SAH), S-adenosyl-L-methionine (SAM) and cyclic adenosine monophosphate (cAMP), respectively. caprotec bioanalytics GmbH...
BioCentury | Jun 2, 2008
Company News

caprotec, Merck KGaA deal

...Merck Serono S.A. subsidiary. Caprotec will receive undisclosed research funding and is eligible for milestones. caprotec bioanalytics GmbH...
Items per page:
1 - 10 of 11
BioCentury | May 19, 2016
Distillery Therapeutics

Therapeutics: Catechol-O-methyl-transferase (COMT)

...Chem.; published online Apr. 13, 2016 doi:10.1021/acs.jmedchem.5b01970 CONTACT: Yan Luo, caprotec bioanalytics GmbH , Berlin, Germany e-mail: yan.luo@caprotec.com BC...
BioCentury | Oct 29, 2012
Company News

caprotec management update

caprotec bioanalytics GmbH , Berlin, Germany Business: Proteomics, Supply/Service Hired: Jonathan Turner as CEO and managing director, formerly SVP at XL Techgroup Inc.; he replaces Hubert Koester, who becomes acting CSO and chairman of the scientific...
BioCentury | May 16, 2011
Financial News

caprotec financial update

...to €5 million ($6.4 million). The company raised €4 million ($4.9 million) in May 2010. caprotec bioanalytics GmbH...
BioCentury | Oct 11, 2010
Company News

caprotec sales and marketing update

...caprotec bioanalytics GmbH , Berlin, Germany Business: Proteomics caprotec bioanalytics launched three new caproKits to investigate...
BioCentury | Oct 11, 2010
Company News

caprotec management update

caprotec bioanalytics GmbH , Berlin, Germany Business: Proteomics, Supply/Service Hired: Rainer Metternich as CBO, COO and a director, formerly VP and basic research site head at Merck & Co. Inc. WIR Staff...
BioCentury | May 24, 2010
Financial News

caprotec completes venture financing

caprotec bioanalytics GmbH , Berlin, Germany Business: Proteomics, Supply/Service Date completed: 5/13/10 Type: Venture financing Raised: €4 million ($4.9 million) Investors: Creathor Venture; IBB Beteiligungsgesellschaft; ERP Startfonds; private investors WIR Staff...
BioCentury | Feb 1, 2010
Company News

caprotec sales and marketing update

...histone deacetylases (HDACs) or GDP/GTP binding proteins, respectively. The kits are available for research use. caprotec bioanalytics GmbH...
BioCentury | Apr 13, 2009
Finance

Ebb & Flow

...company caprotec bioanalytics GmbH . The company markets its caproKits to discover, identify and characterize specific proteins. caprotec...
...Koster said the new round would go to building an internal drug pipeline based on caprotec's...
BioCentury | Jan 26, 2009
Company News

caprotec sales and marketing update

...characterize proteins that interact with S-adenosyl-L-homocysteine (SAH), S-adenosyl-L-methionine (SAM) and cyclic adenosine monophosphate (cAMP), respectively. caprotec bioanalytics GmbH...
BioCentury | Jun 2, 2008
Company News

caprotec, Merck KGaA deal

...Merck Serono S.A. subsidiary. Caprotec will receive undisclosed research funding and is eligible for milestones. caprotec bioanalytics GmbH...
Items per page:
1 - 10 of 11